# Aurora Cannabis Inc. (ACB) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Pharmaceuticals. Price $5.24, market value $332 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Aurora Cannabis Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 1.6×**. Each dollar of revenue is priced at 1.6×.
- **Price / book: 0.9×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 14.6×**. Enterprise value is 14.6× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: -11.0%** (5-yr avg -33.1%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 48.0%**. Aurora Cannabis Inc. keeps 48.0% of revenue after the direct cost of what it sells.
- **Operating margin: -11.5%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -38.0%**. The company reported a net loss over the last twelve months.
- **Return on equity: -23.8%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -9.0%**. Return on all capital, debt included, is -9.0%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -4.6%**. Each dollar of assets produces -4.6% of profit.

## Growth
- **Revenue growth (1 yr): -6.6%** (3-yr 11.2%/yr, 5-yr 5.5%/yr). Revenue fell 6.6% over the last year, against 5.5% a year compounded over five years: growth is slowing.

## Financial health
- **Debt to equity: 0.05**. Debt is 0.05 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Aurora Cannabis Inc. holds more cash than debt.
- **Interest coverage: -7.4×**. Operating profit covers interest only -7.4×: fragile.
- **Current ratio: 5.94** (quick 3.32). Current assets cover the next year's liabilities 5.94 times.
- **Altman Z-score: 3.69**. A Z-score of 3.69 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Aurora Cannabis Inc. does not currently pay a dividend, but it returned -1.6% of its market value through buybacks over the last year.

## Price and momentum
- **Total return (1 yr): 5.7%** (YTD 22.3%, 3-mo 83.6%). The shares are up 5.7% over twelve months including dividends.
- **From 52-week high: -17.6%** (104.7% above the low). Trading 18% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 78**. An RSI of 78 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 1.41** (volatility 61%). Beta of 1.41 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ACB · Page: https://foliofundamentals.com/stocks/acb

Not investment advice.